Back to Search
ISSA KHOURI, MD
MD
Internal Medicine Physician
NPI: 1285712885IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
A78545(CA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 2000
Research & Publications (20)
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
PMID 18411419·Blood·2008
3-trial
Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia.
PMID 17456058·Br J Haematol·2007
3-trial
Reduced-intensity regimens in allogeneic stem-cell transplantation for non-hodgkin lymphoma and chronic lymphocytic leukemia.
PMID 17124088·Hematology Am Soc Hematol Educ Program·2006
6-review
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.
PMID 15800314·J Clin Oncol·2005
3-trial
Low-dose alemtuzumab (Campath) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: decreased incidence of acute graft-versus-host-disease with unique pharmacokinetics.
PMID 14755312·Bone Marrow Transplant·2004
8-other
Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival.
PMID 14725898·Exp Hematol·2004
8-other
Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: the prognostic value of beta2-microglobulin and the tumor score.
PMID 14669282·Cancer·2003
8-other
Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma.
PMID 14645431·J Clin Oncol·2003
8-other
Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy.
PMID 11908196·Cancer Treat Res·2002
6-review
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.
PMID 11739162·Blood·2001
3-trial
Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention.
PMID 19561648·Bone Marrow Transplant·2010
8-other
Autologous and allogeneic stem cell transplantation: rising therapeutic promise for mantle cell lymphoma.
PMID 19562639·Leuk Lymphoma·2009
6-review
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.
PMID 19384931·Am J Hematol·2009
8-other
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
PMID 19144658·Haematologica·2009
8-other
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.
PMID 19168784·Blood·2009
8-other
The role of stem cell transplantation in the management of chronic lymphocytic leukaemia.
PMID 19358149·Hematol Oncol·2009
6-review
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
PMID 19450756·Biol Blood Marrow Transplant·2009
8-other
Advances in mobilization for the optimization of autologous stem cell transplantation.
PMID 19603345·Leuk Lymphoma·2009
6-review
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).
PMID 19041053·Biol Blood Marrow Transplant·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1200 EL CAMINO REAL
SOUTH SAN FRANCISCO, CA 94080 - Phone
- (650) 742-2000
Quick Facts
- NPI
- 1285712885
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile